Polito Angelo, Thiagarajan Ravi R, Laussen Peter C, Gauvreau Kimberlee, Agus Michael S D, Scheurer Mark A, Pigula Frank A, Costello John M
Department of Cardiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Circulation. 2008 Nov 25;118(22):2235-42. doi: 10.1161/CIRCULATIONAHA.108.804286. Epub 2008 Nov 10.
This study sought to determine whether associations exist between perioperative glucose exposure, prolonged hospitalization, and morbid events after complex congenital heart surgery.
Metrics of glucose control, including average, peak, minimum, and SD of glucose levels, and duration of hyperglycemia were determined intraoperatively and for 72 hours after surgery for 378 consecutive high-risk cardiac surgical patients. Multivariable regression analyses were used to determine relationships between these metrics of glucose control, hospital length of stay, and a composite morbidity-mortality outcome after controlling for multiple variables known to influence early outcomes after congenital heart surgery. Intraoperatively, a minimum glucose <or=75 mg/dL was associated with greater adjusted odds of reaching the composite morbidity-mortality end point (odds ratio [OR], 3.10; 95% confidence interval [CI], 1.49 to 6.48), but other metrics of glucose control were not associated with the composite end point or length of stay. Greater duration of hyperglycemia (glucose >126 mg/dL) during the 72 postoperative hours was associated with longer duration of hospitalization (P<0.001). In the 72 hours after surgery, average glucose <110 mg/dL (OR, 7.30; 95% CI, 1.95 to 27.25) or >143 mg/dL (OR, 5.21; 95% CI, 1.37 to 19.89), minimum glucose <or=75 mg/dL (OR, 2.85; 95% CI, 1.38 to 5.88), and peak glucose level >or=250 mg/dL (OR, 2.55; 95% CI, 1.20 to 5.43) were all associated with greater adjusted odds of reaching the composite morbidity-mortality end point.
In children undergoing complex congenital heart surgery, the optimal postoperative glucose range may be 110 to 126 mg/dL. Randomized trials of strict glycemic control achieved with insulin infusions in this patient population are warranted.
本研究旨在确定围手术期血糖暴露、住院时间延长与复杂先天性心脏病手术后不良事件之间是否存在关联。
对378例连续的高危心脏手术患者,术中及术后72小时测定血糖控制指标,包括血糖水平的平均值、峰值、最小值和标准差,以及高血糖持续时间。在控制了已知影响先天性心脏病手术后早期结局的多个变量后,采用多变量回归分析来确定这些血糖控制指标、住院时间和综合发病率 - 死亡率结局之间的关系。术中,最低血糖<或 = 75 mg/dL与达到综合发病率 - 死亡率终点的调整后较高几率相关(比值比[OR],3.10;95%置信区间[CI],1.49至6.48),但其他血糖控制指标与综合终点或住院时间无关。术后72小时内高血糖(血糖>126 mg/dL)持续时间越长,住院时间越长(P<0.001)。术后72小时内,平均血糖<110 mg/dL(OR,7.30;95% CI,1.95至27.25)或>143 mg/dL(OR,5.21;95% CI,1.37至19.89)、最低血糖<或 = 75 mg/dL(OR,2.85;95% CI,1.38至5.88)以及峰值血糖水平>或 = 250 mg/dL(OR,2.55;95% CI,1.20至5.43)均与达到综合发病率 - 死亡率终点的调整后较高几率相关。
在接受复杂先天性心脏病手术的儿童中,术后最佳血糖范围可能为110至126 mg/dL。有必要对该患者群体进行胰岛素输注实现严格血糖控制的随机试验。